ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,485Medicare Part D Prescriptions Filled, Including Refills

Rank: 68 out of 617

$578K Total Retail Price of All Prescriptions

Rank: 57 out of 617

334 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 334 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 334 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 9,710 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
OMEPRAZOLE 511 449 1 3
FUROSEMIDE 437 427 2 4
LISINOPRIL 384 340 3 5
AMLODIPINE BESYLATE 366 326 4 6
SIMVASTATIN 345 329 5 2
WARFARIN SODIUM 329 307 6 7
HYDROCODONE-ACETAMINOPHEN 307 182 S3 7 8
POTASSIUM CHLORIDE 295 268 8 10
METOPROLOL SUCCINATE 289 277 9 12
LEVOTHYROXINE SODIUM 271 261 10 1
METOPROLOL TARTRATE 218 144 11 11
METFORMIN HCL 184 175 12 9
GABAPENTIN 172 136 13 16
ALLOPURINOL 164 148 14 27
HYDROCHLOROTHIAZIDE 144 137 15 13
CARVEDILOL 137 137 16 19
BENAZEPRIL HCL 134 134 17 44
PANTOPRAZOLE SODIUM 129 113 18 37
DIGOXIN 126 126 19 48
LOSARTAN POTASSIUM 120 120 20 22
SERTRALINE HCL 116 113 21 20
TRAMADOL HCL 106 84 22 15
ADVAIR DISKUS 106 88 22 38
PREDNISONE 103 81 24 31
FENTANYL 102 54 S2 25 45
DIOVAN 93 86 26 41
ALENDRONATE SODIUM 89 76 27 25
PRAVASTATIN SODIUM 86 86 28 21
NAMENDA 82 82 29 35
CYCLOBENZAPRINE HCL 80 29 R 30 74
VENLAFAXINE HCL ER 75 36 31 76
CRESTOR 75 66 31 28
CELEBREX 74 67 33 63
CITALOPRAM HBR 73 52 34 18
CEFUROXIME 73 58 34 165
POLYETHYLENE GLYCOL 3350 72 62 36 32
LANTUS 71 57 37 39
ZOLPIDEM TARTRATE 70 37 38 23
DONEPEZIL HCL 67 67 39 30
SPIRIVA 67 60 39 61
OXYCODONE-ACETAMINOPHEN 66 52 S2 41 93
RANITIDINE HCL 66 49 41 40
RISPERIDONE 65 63 43 71
TRAZODONE HCL 65 50 43 51
SPIRONOLACTONE 63 63 45 42
FLUTICASONE PROPIONATE 62 53 46 36
VERAPAMIL ER 62 47 46 90
LYRICA 61 26 48 92
TERAZOSIN HCL 61 61 48 96
GLIPIZIDE 60 60 50 82
ROPINIROLE HCL 60 54 50 66
CYMBALTA 57 35 52 49
TAMSULOSIN HCL 56 44 53 26
ATORVASTATIN CALCIUM 54 52 54 14
AMITRIPTYLINE HCL 54 49 R 54 56
FENOFIBRATE 53 37 56 58
NEXIUM 51 46 57 43
TRIAMCINOLONE ACETONIDE 51 41 57 102
QUETIAPINE FUMARATE 50 49 59 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 29, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.